ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands

Enzo Biochem, Inc. (ENZ) delivered a loss per share of 19 cents from continuing operations in fiscal 2024, narrower than the loss of 51 cents per share in the comparable fiscal 2023 period. Enzo Biochem's Revenues in Detail Enzo Biochem's Life Sciences Products reporting unit operates in one reportable segment, Products. The company's Products revenues were $7.5 million in the fiscal fourth quarter, down 16% year over year. This was due to a shift in ordering patterns. The company's Products revenues were $ ...